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INTRODUCTION 
This is evidenced by the WHO report where it was ex-
hibited that in creating nations, half of all popular up-
per respiratory tract diseases and viral infection cases 
got anti-infection agents improperly while just 70% of 
all pneumonia cases, which warrant anti-infection 
treatment, antibiotics[1]. This inappropriate antibiotic 
utilize has numerous outcomes including serious mor-
bidity and mortality coming about because of wrong 
dose, antagonistic medication response, and expanded 
Antibiotic obstruction coming about because of abuse 
of anti-infection agents. In 2011, the WHO expressed 
“if no action today, no cure tomorrow”[2] in an effort 
to emphasize to the consequence of the widespread 
and inadvertent use of antibiotics and the need for 
immediate action to preserve antibiotics for future use. 
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Infectious diseases represent a major cause of morbidi-
ty and mortality in India and are responsible for a large 
proportion of hospital admissions, particularly in chil-
dren. Antibiotics and other Antibiotics, therefore, con-
stitute an important category of drugs, both in the 
community and in hospitals. There is considerable evi-
dence linking indiscriminate use of Antibiotics to al-
tered susceptibility patterns among infectious organ-
isms and often frank resistance[3]. We face huge chal-
lenges in rational use of Antibiotics starting with gen-
eral lack of awareness and unsatisfactory levels of per-
sonal hygiene and environmental sanitation to lack of 
surveillance mechanisms for monitoring Antibiotic use 
and resistance, mostly empirical use of antibiotics due 
to dearth of microbiology laboratory support, absence 
of or ineffective antibiotic use policies in most 
healthcare settings and nonhuman use of Antibiotics [4
-6]. 
The nature and pattern of Antibiotic prescribing chang-
es with time as spectrum of pathogens change and new 
Antibiotics are introduced. In India, Antibiotics may 
account for 50% of total value of drugs sold, but the 
prevalence of Antibiotic use has varied across surveys
[7]. With widespread use of antibiotics, the prevalence 
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of resistance also increases. The association of re-
sistance with the use of Antibiotics agents has been 
documented in both in-and-outpatient settings [8, 9]. 
The occurrence of adverse drug reactions (ADRs) is an-
other problem with Antibiotic use. ADRs in pediatric 
population may have relatively more severe effect than 
adults leading to significant morbidity among children 
[10]. A systematic review published some time back 
reported the incidence of pediatric ADRs at 9.5%, re-
sponsible for 2.1% of hospital admissions, with 39.3% 
of them being life‑threatening [11]. A study of ADR 
burden in children in South India found that ADRs oc-
curred more among infants and antibiotics were com-
monly implicated [12]. 
Rational use of Antibiotics in the long run, therefore, 
demands continuous survey of Antibiotic use and relat-
ed ADR monitoring [13]. Patterns of use in children 
need to be studied separately as they will vary from use 
in adults. However, there is limited data in this respect 
from India and no recent data from the Southern re-
gion. With this background, we planned to observe 
Antibiotic use in pediatric medicine ward of our tertiary 
care hospital to generate data regarding Antibiotic utili-
zation and related ADRs. 
MATERIALS AND METHODS 
Study design: Descriptive study  
Ethics approval: Institutional Ethics Committee approv-
al was obtained beforehand. Written informed consent 
was obtained from a parent or legal guardian, with the 
provision of a witness when the guardian was illiterate. 
Study duration: Study was carried out over period of 
18 months (February 2016–August 2017) 
Study place: The study was carried out among inpa-
tients admitted to the pediatric medicine ward of a 
tertiary care teaching hospital (Osmania General Hospi-
tal, Hyderabad).  
The Pediatrics Medicine Department admits 8–14 pa-
tients daily on an average.  
Inclusion criteria: Subjects of both sex and age be-
tween 1 month to 12 years were recruited into if 
they’re in house prescriptions contained Antibiotic 
agents.  
Exclusion criteria: Seriously ill children were excluded.  
Sampling method: Sampling was purposive. Recruit-
ment was done in 1–2 days per week and every effort 
was made to recruit all children admitted on a study 
day if they satisfied inclusion criteria. The recruitment 
days corresponded to the fixed admission days of the 
pediatrician investigator, and once recruited the child 
was followed up till discharge, shifting to the Pediatric 
Intensive Care Unit (PICU), or death. Although the re-
cruitment of new subjects was done on fixed days of 
the week, the researchers visited the wards as often as 
required to keep complete track of the medication be-
ing used by every recruited subject. 
Sample size: A total of 292 patients admitted to the 
pediatric medicine ward were recruited during the 
study period.   
Methodology: Antibiotics are supplied free in the hos-
pital. Our operational definition of antibiotic agent in-
cluded synthetic as well as naturally obtained drugs 
that attenuate microorganisms, subsequently covering 
all antibacterial, antifungal, antiviral, and antiproto-
zoals agents. Standard statistic and clinical features, 
duration of hospital stay, antibiotics received in the 
hospital along with dosing and indication and details of 
suspected ADRs attributable to their use were record-
ed. Information was captured on a structured case re-
port form. ADR data were captured on the ADR moni-
toring form of Pharmacovigilance Programme of India 
(PvPI) [14].  
Statistical analysis:  The data have been summarized 
by routine descriptive statistics, namely mean and 
standard deviation for numerical variables, additionally 
median and interquartile range for skewed variables 
and counts and percentages for categorical variables. 
The 95% confidence interval (CI) has been presented 
for key figures. Origin Pro 7.6 statistical software was 
used for analysis. 
RESULTS 
During the 18 months study, a total of 292 patients 
admitted to the pediatric medicine ward were recruit-
ed. These 292 came from 364 eligible subjects; that is 
patients admitted to the pediatric ward on the study 
days if they consented to be part of the study. Of them, 
72 were not given Antibiotic prescriptions. Thus, the 
Anthropometric parameter Range Mean±SD Median (IQR) 
Weight at admission (kg) 1.5-32 13.6 ± 5.8 11.03 (6.8-18.9) 
Height at admission (cm) 40.0- 135.0 87.3  ± 9.8 85.0 (65.0- 109.8) 
Birth weight (kg) 0.8-3.6 2.4  ± 1.1 2.2 (2.0- 2.5) 
Head circumference (cm) 28.0-58.0 38.6 ± 3.76 39.0 (38.0- 40.0) 
Table 1. Anthropometric data for the study population  
*Measured in subjects aged 12 months or less. IQR=Interquartile range, SD=Standard deviation 
Over the 18months study, the total number of antibiotic agents prescribed to the 292 children was 589. Table 2 
provides a snapshot of this antibiotic use.  
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prevalence of antibiotic use was 80.22% (95% CI 75.0%
–85.0%). 
Among these 292 children, 185 (63.35%) were males. 
The majority of the children belonged to the preschool 
age group, with the median age at 35.0 (interquartile 
range 8.0–96.0) months. The anthropometric data are 
summarized in Table 1 and indicates that the children 
were of average height and weight in consonance with 
their age.  
Parameter Value 
Total numbers of antibiotic agents: prescribed 589 in 292 cases 
Number of antibiotics per patient: 
Range 1-12 
Mean 2.2 ± 1.1 
Median 2.0 (1-2) 
Duration of antibiotic treatment (excluding anti tubercular drugs) (days): 
Range 1-32 
Mean 7.1 ± 5.8 
Median 8.0 (4-8) 
Duration of hospital stay (days): 
Range 1-38 
Mean 8.8  ± 6.6 
Median 8.0 (5-11) 
Percentage of antibiotics as injections: 82.78 
Table 2. Antibiotic use in study subjects  
IQR=Interquartile range 
  RTI GIT CVS CNS GU
T 
Sepsis SST Other 
INF 
Fever NOS TOX To-
tal 
Cephalosporins* 62 19 23 36 38 6 3 4 18 31 240 
Other –β-lactams 
+ vancomycins** 
59 8 18 26 28 7 3 - 11 13 173 
Amikacin 23 5 13 8 7 3 - - 6 3 68 
Metronidazole - 8 - 4 5 2 - - - 5 24 
Fluoroquinolones 3 4 3 2 6 - - - - - 18 
Antitubercular - - - 16 - - - - - - 16 
Macrolides 6 - 3 1 3 - - - 1 3 17 
Aciclovir - - - 5 1 - - - - 4 10 
Linezolid 1 - - 3 - 2 - - - 3 9 
Antimalarials - - - 3 - - - 5 1 - 9 
Co‑trimoxazole - - - - 1 - - - - - 1 
Mupirocin - - - - - - 2 - - - 2 
Amphotericin B - - - 2 - - - - - - 2 
Total 154 44 60 106 89 20 8 9 37 62 589 
Table 3: System wise breakup of individual antibiotic use in 265 children 
*The cephalosporins included ceftriaxone (198), cefotaxime (10), cefpodoxime (9), cefoperazone (9), cefipime (6), 
cefixime (3), cefuroxime (3), cefalexin (1) and ceftazidime (1); **This group included co-amoxiclav (74), ampicillin 
(28), piperacillin-tazobactam (14), amoxicillin (8), meropenem (14), penicillin V (3), benzathine penicillin (1), 
imipenem (1) and vancomycin (30); CNS=Central nervous system, CVS=Cardiovascular system, Fever NOS=Fever 
not otherwise specified, GIT=Gastrointestinal tract, GUT=Genitourinary tract, INF=Infection, RTI=Respiratory 
tract infections, SST=Skin and soft tissue infection, TOX=Toxicities (poisonings) and miscellaneous 
Sunil et al.  Antibiotic use in pediatric infections: A study in tertiary care hospital. 
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The highest number of antibiotic prescriptions were 
from the cephalosporin class (240; 40.74%) while co-
trimoxazole, amphotericin B and mupirocin (0.84% 
each) were used sparingly. Ceftriaxone was the single 
most frequently prescribed drug (33.61%). Among the 
240 instances of cephalosporin use, the highest pre-
scribed was ceftriaxone (198; 82.5%) whereas cefalexin 
(0.16%) and ceftazidime (0.16%) were used the least. 
The majority of the cephalosporins were prescribed for 
respiratory tract infections (62; 25.83%) and the least 
for soft tissue infections (3; 1.25%). Penicillins, other β-
lactams, and vancomycin accounted for 173 (29.37%) 
instances. Co-amoxiclav (12.56%) and ampicillin 
(4.75%) were prescribed more frequently; whereas 
benzathine penicillin and imipenem (0.16% each) were 
used sparingly. Highest numbers in this group were 
prescribed for respiratory tract infections (34.10%) and 
the lowest for skin and soft tissue infections (1.73%). 
Fig. 1 and Table 3 provide a system-wise break-up of 
the 589 instances of antibiotic use.  
Overall, the highest numbers of antibiotic agents were 
prescribed for respiratory tract infections (154, 26.15%) 
followed by infections involving the central nervous 
system (CNS) (106, 17.99%) and the genitourinary tract 
(89, 15.11%). Among the total number of antibiotic 
prescriptions for respiratory tract infections; the high-
est numbers were prescribed from other β-lactam 
group followed by cephalosporins and aminoglyco-
sides. For CNS infections, highest numbers were pre-
scribed from cephalosporin class followed by other β-
lactams and antitubercular drugs. For fever without 
specification of cause, antibiotics prescribed (6.28%) 
included cephalosporins, other β-lactams, and amika-
cin. 
It was found 109 (37.32%) that prescriptions contained 
a single antibiotic agent, 121 (41.43%) contained two 
and 62 (21.23%) contained either three or more than 
three antibiotic agents. 
Analyzing the dosage forms used, it was observed that 
the majority (478; 81.15%) of the antibiotics were ad-
ministered intravenously and the rest by oral route 
(111; 18.84%). Only mupirocin was used topically. The 
great majority (583; 98.98%) were prescribed in generic 
name. The several brand name prescriptions included 
ATD combinations, piperacillin-tazobactam, and ceftri-
axone in a single instance. 
In most children (84.89%) antibiotic therapy was empir-
ical and based on clinical judgment. In 15.11% cases, 
treatment was guided by results of laboratory tests, 
including 28 (9.58%) instances of blood culture and 12 
(4.1%) of cerebrospinal fluid examination. Peripheral 
blood smears were examined in suspected malaria cas-
es. Only 9 specimens out of 28 sent for blood culture 
showed positive results, with Staphylococcus aureus 
isolated in five.  
ADRs, of at least “possible” causality, were noted in 5 
(1.71%) children, of which half were cutaneous reac-
tions and the rest loose stools. Vancomycin was re-
sponsible for skin rash in 4 cases, while ampicillin was 
responsible for loose stool in 3 cases and amoxicillin in 
1 case. Although the reactions were not deemed to be 
serious, vancomycin was replaced by suitable alterna-
tives in the skin rash cases. Out of 292 patients studied 
most were either discharged (234; 80.13%) or shifted 
to the PICU (53; 18.15%). However, 5 babies (1.71%) in 
the study cohort died from their illness. ADRs were not 












 Beta lactams/ Vancomycin
 Cephalosporins
Figure 1. Percentage frequency of use of individual groups of antibiotics in 292 children (n = 589)  
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implicated in any of the instances of death or worsen-
ing of disease. 
DISCUSSION 
In this investigation, around 63% of the subjects were 
male. These statistic figures are extensively like reports 
from open public hospitals in other developing coun-
tries, for example, Ethiopia [15-17] and Nepal [18]. The 
most widely indication for antibiotic use in our series 
was pneumonia (10.2%), trailed by other lower respira-
tory tract diseases (9.4%). Among the antibiotics pre-
scribed for respiratory tract diseases; the majority were 
cephalosporins or different β lactams followed by van-
comycin and amikacin. An investigation did in Kath-
mandu Valley, Nepal18, also observed that pneumonia 
was the most common diagnosis for in hospital antibi-
otic use. 
In this study, cephalosporins (40.74%) were most gen-
erally prescribed antibiotics followed by other mem-
bers of the β-lactam class and aminoglycosides. Ceftri-
axone (33.61%), Co-amoxiclav (12.56%) and amikacin 
(11.54%) were most frequently prescribed.  
The Kathmandu Valley study[18] announced that ceph-
alosporins were the most commonly prescribed antibi-
otics followed by penicillins. Among cephalosporins, 
ceftriaxone was frequently prescribed.  An investigation 
did in a tertiary hospital in Bangladesh report that am-
picillin, gentamicin, amoxicillin, cloxacillin and ceftriax-
one were prescribed frequently[19]. A comparative 
report did in eastern nepal reported that gentamicin, 
ampicillin, crystalline penicillin, and cefotaxime were 
the most commonly prescribed antibiotics [20].  A 
study in Chandigarh by sharma et al and deshmukh et 
al[21, 22] demonstrated that aminoglycosides 
(amikacin), cephalosporins (cefotaxime), quinolones 
(ciprofloxacin), and cloxacillin were most much of the 
time prescribed. Thus, so far as the pattern of antibiotic 
use is concerned, our experience broadly conforms to 
that of other authors reporting prescribing trends for 
inpatients in similar socio-economic settings. It is note-
worthy that our hospital does not have a standing in-
fection control committee or antibiotic use policy that 
would have constrained choice of drugs. 
Percentage of encounters with an antibiotic prescribed 
(almos 80% in our case) and normal number of antibi-
otics per prescription have been considered as essen-
tial markers for rational use of medicines in out-patient 
primary care23. To minimize the risk of drug-drug inter-
actions, development of bacterial resistance and costs, 
it is preferable to keep the number of drugs per pre-
scription as low as possible. In our study, around 60% 
prescriptions contained either two or more than two 
antibiotics, with the median number at two. Prajapati 
and Bhatt [7], announced that mean number of drugs 
per prescription was 1.97 and number of prescriptions 
with two or more antibiotic agents was around 71%. 
sharma et al[21]. Observed that prescribing of two anti-
biotics was common (around 60%) in pediatric cases. 
However, the study carried out in Kathmandu Valley18 
reported that the significant portion (93%) of patients 
was prescribed one antibiotic. Thus, prima facie the 
situation in India, and particularly in our setting, offers 
scope for improvement. 
We found that 81.15% antibiotic agents were pre-
scribed by parenteral routes, while only 18.84% were 
for oral utilize; 98.98% were prescribed in generic 
name. The prevalence of parenteral administration can 
be explained in the context of inpatients that are likely 
to be more seriously ill than patients who can be man-
aged on ambulatory basis. Still the figure for injections 
appears to be high and calls for investigation through 
prescription audit and formulation of antibiotic guide-
lines. Comparative concerns have been voiced in a re-
cent latvian investigation on antibiotic usage among 
hospitalized children, including neonates[24]. The near 
100% generic prescribing is a desirable situation. We 
feel that this owes to a large extent on local govern-
ment policy that seeks to enforce generic prescribing in 
public hospitals. 
Ideally, in any large hospital, antibiotic prescribing 
should be governed by appropriate guidelines support-
ed by antibiotic resistance observation. Unfortunately, 
our institution currently does not have an active sur-
veillance program or updated guidelines.In the consid-
erable dominant part of cases, initial drug choice was 
empirical and antibiotic treatment was guided by the 
results of laboratory tests in just 15.11% cases; which 
are far from satisfactory. Furthermore, the low yield of 
culture tests, as noted in our case, often frustrate clini-
cians.  A similar circumstance is by all accounts winning 
in the settings for prior examinations[18]. This is a 
grossly undesirable situation since antibiotic use guide-
lines supported through appropriate surveillance is 
regarded as a fundamental prerequisite for rational 
antibiotic use[25]. Notwithstanding continuous spread 
of antibiotic resistance coupled with declining rate of 
new antibiotic improvement a lot of emphasis is being 
accorded of late to antibiotic stewardship programs 
(ASPs) in hospitals[26]. However, although ASPs can be 
effective in enhancing the quality and safety of antibi-
otic prescribing for hospitalized patients, there are 
unique issues relevant to children and pediatric ASPs 
are still in their infancy[27, 28]. 
In our study, suspected ADRs were noted in just 1.71% 
cases and were prevalently cutaneous reactions or 
loose stool. Thus, the ADR burden was quite managea-
ble. Priyadharsini et al [12] in their study on ADRs in 
pediatric patients reported that antibiotics were re-
sponsible for a large share of the burden and urticaria 
and different rashes were the most common ADRs 
attributable to antibiotics. The hospital being part of an 
ADR Monitoring Center under PvPI, these reports were 
properly submitted to PvPI. However, as yet there have 
no feedback sessions in this regard for the physicians 
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The present examination has its share of limitations. 
For logistical reasons, subject recruitment was not 
done consistently basis and sampling was purposive 
rather than random. In any case, the prospective data 
collection has ensured that for subjects recruited we 
have reliable data. Neonates and PICU patients were 
not a part of the study, but drug use patterns in such 
children also need to be addressed. 
CONCLUSION 
Nevertheless, in conclusion, we can state that this ex-
amination profiles antibiotic use in hospitalized chil-
dren in our organization and the situation is likely to be 
representative of other public hospitals catering to 
poor patients. Utilization of well‑known antibiotics and 
generic prescribing are satisfactory trends noted. On 
the flip side, numerous antibiotics in the similar patient 
and commonplace utilization of injections are matters 
of concern. Furthermore, decision of anti-microbial 
being generally empirical there may be a tendency to 
use more expensive cephalosporins in lieu of less ex-
pensive drugs.  
Suggestions: We hope that these findings can be uti-
lized in conjunction with antibiotic resistance surveil-
lance data in formulating antibiotic use guidelines for 
pediatric wards. Medication utilize overviews in differ-
ent settings, for example, pediatric OPD and PICU are 
required before wandering into the improvement of 
comprehensive pediatric anti-microbial utilize rules. 
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